VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Ultra Conservative ICD Programming
Other: Traditional ICD Programming

First Posted Date: 2013-11-07

Last Posted Date: 2017-08-16

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 80

Registration Number: NCT01977703

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

Phase 4

Completed

Conditions: Atrial Flutter
Atrial Fibrillation

Interventions: Drug: dabigatran etexilate mesylate

First Posted Date: 2013-11-05

Last Posted Date: 2017-09-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 101

Registration Number: NCT01976507

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia

Phase 2

Completed

Conditions: Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

Interventions: Drug: Montelukast added to Hydroxyurea
Drug: Placebo added to Hydroxyurea

First Posted Date: 2013-10-10

Last Posted Date: 2019-03-26

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 46

Registration Number: NCT01960413

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study

Phase 4

Withdrawn

Conditions: Subarachnoid Hemorrhage
Seizures

Interventions: Drug: levetiracetam

First Posted Date: 2013-09-05

Last Posted Date: 2017-11-01

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT01935908

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery

Completed

Conditions: Muscle Weakness

Interventions: Device: TOF-Watch SX
Procedure: Notify the provider

First Posted Date: 2013-09-02

Last Posted Date: 2019-09-04

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 201

Registration Number: NCT01933841

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction

Not Applicable

Completed

Conditions: Distal Bile Duct Obstruction

Interventions: Device: Covered Self-expanding metal biliary stents (C-SEMS)
Device: Uncovered Self-expanding metal biliary stents (U-SEMS)

First Posted Date: 2013-07-23

Last Posted Date: 2022-03-31

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 6

Registration Number: NCT01905384

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Mount Sinai Hospital, New York, New York, United States

Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test, Link and Care (TLC)

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: Enhancing HIV testing

First Posted Date: 2013-07-22

Last Posted Date: 2017-04-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 3760

Registration Number: NCT01904877

Hormonal, Metabolic, and Signaling Interactions in PAH

Recruiting

Conditions: Scleroderma Associated Pulmonary Arterial Hypertension
Idiopathic Pulmonary Arterial Hypertension
Heritable Pulmonary Arterial Hypertension
Appetite Suppressant Associate PAH

First Posted Date: 2013-06-21

Last Posted Date: 2023-09-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1899

Registration Number: NCT01884051

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Sickle Cell Disease - Stroke Prevention in Nigeria Trial

Not Applicable

Completed

Conditions: Stroke
Sickle Cell Anemia
Sickle Cell Disease

Interventions: Drug: Hydroxyurea

First Posted Date: 2013-02-28

Last Posted Date: 2020-08-03

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 29

Registration Number: NCT01801423

Locations: 🇳🇬
Aminu Kano Teaching Hospital, Kano, Nigeria

Nicotine Treatment of Cognitive Decline in Down Syndrome

Phase 1

Completed

Conditions: Down Syndrome
Mild Cognitive Impairment

Interventions: Drug: Low Dose Nicotine (7mg)
Drug: Moderate Dose Nicotine (14mg)

First Posted Date: 2013-01-29

Last Posted Date: 2022-05-10

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 7

Registration Number: NCT01778946

Locations: 🇺🇸
Vanderbilt Psychiatric Hospital, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy